MSD Renal Cell Centre Expert Academy video transcript
The team really pay attention to the brief, they take the time to understand
what our learning objectives are and they really work as a group to think
collectively how can they maximise the events using the knowledge of all of the
the people that are on hand and available to help us understand better.
I know that everybody that’s been here over the last couple of days will take
that information into every single interaction that they have.
I think it’s just important for us to immerse ourselves into the customer’s
reality, so the customers being our clinicians, but also, the patients.
It also gives us a really good opportunity to learn together as a team and to
all be on the same baseline so we know exactly what we’re dealing with.
I think I’ve started to think about kidney cancer from a very different perspective,
focusing on all the various healthcare professionals that patient may see, not necessarily
just the small area that we can focus on, on our daily basis. I think the course
has been hugely beneficial for me, in my role, because I get much more of a huge
sense now of how the multi-disciplinary team works for that patient, the number of
healthcare professionals they may see in their in their treatment journey.
Within my role I focus very much on the end stage and the systemic treatment, but
just seeing how much goes into that pathway before that systemic treatment is even
really thought about and has just been incredible. With this, it’s been, ‘can we keep
going?’, ‘can we ask more questions?’, ‘can we find out a little bit more and dig a
little bit deeper?’ because I think it’s everybody, no matter what their
background’s been, has just found it so, so beneficial.
The event has been extremely slick in the way that it’s been
organised. The preparation that the team have put into to make sure that the content
is appropriate for the audience has been incredible.
I think the way that the course has been run has been amazing, it’s been so smooth
it’s been so professional but then also really relatable, I think, to anybody
within the room, who, no matter what background they’ve come from, everything’s been
explained so, so clearly, and, yeah, it’s been a really enjoyable experience.
The main things are taking away from this course are the case workload as well as
the number of people who need to work in a team to make care as efficient as it can
be for the patient. I think I’ll take away mostly how multidisciplinary this
treatment really is. We speak, you know, been speaking to pathologists,
urologists, oncologists, clinical specialists, it’s a real sense of all these
specialties coming together. I think the MDT session we observed really brought that to life.
I think the thing that I’ll take away the most is
just the amount of teamwork that goes into all the decisions that are made
from the whole multidisciplinary team, the amount of communication that
requires, everybody is experts in their own rights but then sharing those
expertise with their colleagues has just been absolutely incremental to the effect of
patient care that has been going on. I think for me,
personally, what’s benefited me the most is I think within my role I focus very much
on the end stage and the systemic treatment but just seeing
how much goes into that pathway before that systemic treatment is even really
thought about and has just been incredible, yeah.